fludarabine has been researched along with Lupus Erythematosus, Systemic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandrova, IY; Grishina, GV; Kozlov, VA; Makarov, SV; Minaev, YL; Mishchenko, OV; Rossiev, VA; Semagina, OV | 1 |
| Kiss, E; Szodoray, P | 1 |
| Bishop, RJ; Caruso, R; Chan, CC; Cunningham, D; Ding, X; Heller, CK; Illei, G; Pavletic, S | 1 |
| Balow, JE; Bolan, CD; Boumpas, DT; Illei, GG; Klippel, JH; Leitman, SF; Popovsky, MA; Tisdale, JF | 1 |
| Robak, E; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
| Shen, JP; Ye, BD; Zhou, YH | 1 |
| Faure, I; Leng, B; Mercié, P; Pellegrin, JL; Viallard, JF | 1 |
2 review(s) available for fludarabine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Novel therapeutic approaches in systemic lupus erythematosus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Cyclophosphamide; Cytokines; Humans; Immunotherapy; Interferons; Lupus Erythematosus, Systemic; Rituximab; Signal Transduction; Stem Cell Transplantation; T-Lymphocytes; Vidarabine | 2010 |
[Progress and perspectives in the treatment of systemic lupus erythematosus].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antineoplastic Agents, Alkylating; Azathioprine; Cladribine; Cyclophosphamide; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Vidarabine | 2005 |
5 other study(ies) available for fludarabine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
[The role and place of high-dose immunosuppressive therapy and autologous transplantation of hematopoietic stem cells for autoimmune diseases].
Topics: Adult; Age Factors; Antilymphocyte Serum; Arthritis, Rheumatoid; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Melphalan; Multiple Sclerosis; Patient Acuity; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vidarabine | 2016 |
Rapid vision loss associated with fludarabine administration.
Topics: Antineoplastic Agents; Blindness; Brain Diseases; Electroretinography; Evoked Potentials, Visual; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Myeloablative Agonists; Retina; Retinal Diseases; Retrospective Studies; Vidarabine; Young Adult | 2010 |
Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Erythrocyte Transfusion; Fatal Outcome; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Platelet Transfusion; Risk Factors; Vidarabine | 2003 |
[Treatment of refractory severe autoimmune disease by combined therapy with Chinese drug and autohemopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antilymphocyte Serum; Autoimmune Diseases; Combined Modality Therapy; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hematopoietic Stem Cell Transplantation; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Phytotherapy; Transplantation, Autologous; Treatment Outcome; Vidarabine; Young Adult | 2008 |
Successful treatment of lupus with fludarabine.
Topics: Antineoplastic Agents; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Erythematosus, Systemic; Male; Middle Aged; Vidarabine | 1999 |